机译:Calypso试验的临床结果显示,复发性卵巢癌中PEG-脂质体阿霉素和卡铂优于紫杉醇和卡铂:奥地利妇科肿瘤专家会议的结果
Department of Gynecology and Obstetrics Medical University of Graz Graz Austria;
Department of Gynecology and Obstetrics Medical University of Vienna Vienna Austria;
Department of Gynecology Hospital of the Sisters of Charity Linz Austria;
Hospital Barmherzige Brüder Graz Graz Austria;
Department of Gynecology and Obstetrics Medical University of Innsbruck Innsbruck Austria;
Department of Gynecology Hospital of the Sisters of Charity Ried Austria;
Hanuschkrankenhaus Vienna Austria;
Department of Gynecology Hospital of the Sisters of Charity Linz Austria;
Krankenhaus Hietzing Vienna Austria;
Department of Gynecology and Obstetrics Medical University of Innsbruck Innsbruck Austria;
Paclitaxel; Carboplatin; Pegylated liposomal doxorubicin; Platinum-sensitive recurrence; Ovarian cancer; Neuropathy; Alopecia;
机译:老年患者的卵巢癌:卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇在晚期复发中的应用:妇科癌症小组(GCIG)CALYPSO子研究。
机译:老年患者的卵巢癌:晚期复发中卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇的比较:妇科癌症小组(GCIG)CALYPSO子研究
机译:卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇对高度铂敏感的卵巢癌患者的比较:来自CALYPSO III期试验的子集分析结果
机译:腹膜内(I.P,I.P)对腹膜转移的预防和治疗晚期胃癌(I.P。)脂质体 - 卡铂(Lipo-CBDCA)的施用及其在腹膜癌症中的临床试验(P.C。)。
机译:卡铂和环孢菌素A在复发性上皮性卵巢癌治疗中的应用。
机译:聚乙二醇化脂质体阿霉素和卡铂与紫杉醇和卡铂在铂敏感型卵巢癌患者中进行的III期GCIG CALYPSO试验的最终总体生存结果
机译:聚乙二醇化脂质体阿霉素和卡铂与紫杉醇和卡铂在铂敏感型卵巢癌患者中进行的III期GCIG CALYPSO试验的最终总体生存结果